Literature DB >> 29192301

Vision Loss Secondary to Autologous Adipose Stem Cell Injections: A Rising Problem.

Andrew J Rong1, Byron L Lam1, Zubair A Ansari1, Thomas A Albini1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29192301     DOI： 10.1001/jamaophthalmol.2017.5453

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  10 in total

1.  Assessing "Cell Therapy" Clinics Offering Treatments of Ocular Conditions using Direct-to-Consumer Marketing Websites in the United States.

Authors:  Rajinder S Nirwan; Thomas A Albini; Jayanth Sridhar; Harry W Flynn; Ajay E Kuriyan
Journal:  Ophthalmology       Date:  2019-03-21       Impact factor: 12.079

Review 2.  Retinal stem cell transplantation: Balancing safety and potential.

Authors:  Mandeep S Singh; Susanna S Park; Thomas A Albini; M Valeria Canto-Soler; Henry Klassen; Robert E MacLaren; Masayo Takahashi; Aaron Nagiel; Steven D Schwartz; Kapil Bharti
Journal:  Prog Retin Eye Res       Date:  2019-09-05       Impact factor: 21.198

Review 3.  Interaction Between Mesenchymal Stem Cells and Retinal Degenerative Microenvironment.

Authors:  Yu Lin; Xiang Ren; Yongjiang Chen; Danian Chen
Journal:  Front Neurosci       Date:  2021-01-21       Impact factor: 4.677

4.  Intravitreal Administration Effect of Adipose-Derived Mesenchymal Stromal Cells Combined with Anti-VEGF Nanocarriers, in a Pharmaceutically Induced Animal Model of Retinal Vein Occlusion.

Authors:  Eleni Gounari; Anastasia Komnenou; Evangelia Kofidou; Stavroula Nanaki; Dimitrios Bikiaris; Stavroula Almpanidou; Kokkona Kouzi; Vasileios Karampatakis; George Koliakos
Journal:  Stem Cells Int       Date:  2022-02-23       Impact factor: 5.443

5.  Administration of Melatonin in Diabetic Retinopathy Is Effective and Improves the Efficacy of Mesenchymal Stem Cell Treatment.

Authors:  Samraa H Abdel-Kawi; Khalid S Hashem
Journal:  Stem Cells Int       Date:  2022-04-11       Impact factor: 5.131

Review 6.  New Aspects on the Treatment of Retinopathy of Prematurity: Currently Available Therapies and Emerging Novel Therapeutics.

Authors:  Juhee Ryu
Journal:  Int J Mol Sci       Date:  2022-08-01       Impact factor: 6.208

7.  A Long-Term Safety and Efficacy Report on Intravitreal Delivery of Adipose Stem Cells and Secretome on Visual Deficits After Traumatic Brain Injury.

Authors:  Pratheepa Kumari Rasiah; Kumar Abhiram Jha; Jordy Gentry; Nobel A Del Mar; Tanisha Townsend; Kwame E Torgbe; Anton Reiner; Rajashekhar Gangaraju
Journal:  Transl Vis Sci Technol       Date:  2022-10-03       Impact factor: 3.048

Review 8.  Advancing Clinical Trials for Inherited Retinal Diseases: Recommendations from the Second Monaciano Symposium.

Authors:  Debra A Thompson; Alessandro Iannaccone; Robin R Ali; Vadim Y Arshavsky; Isabelle Audo; James W B Bainbridge; Cagri G Besirli; David G Birch; Kari E Branham; Artur V Cideciyan; Steven P Daiger; Deniz Dalkara; Jacque L Duncan; Abigail T Fahim; John G Flannery; Roberto Gattegna; John R Heckenlively; Elise Heon; K Thiran Jayasundera; Naheed W Khan; Henry Klassen; Bart P Leroy; Robert S Molday; David C Musch; Mark E Pennesi; Simon M Petersen-Jones; Eric A Pierce; Rajesh C Rao; Thomas A Reh; Jose A Sahel; Dror Sharon; Paul A Sieving; Enrica Strettoi; Paul Yang; David N Zacks
Journal:  Transl Vis Sci Technol       Date:  2020-06-03       Impact factor: 3.283

9.  Chronic retinal detachment and neovascular glaucoma after intravitreal stem cell injection for Usher Syndrome.

Authors:  Kay T Khine; Thomas A Albini; Richard K Lee
Journal:  Am J Ophthalmol Case Rep       Date:  2020-03-07

Review 10.  Stem Cell Therapy for Retinal Degeneration: The Evidence to Date.

Authors:  Amit Sharma; Bithiah Grace Jaganathan
Journal:  Biologics       Date:  2021-07-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.